• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of Long COVID or Post COVID syndrome: A Pharmacological approach.

作者信息

Banerjee Indrajit, Robinson Jared, Sathian Brijesh

机构信息

Sir Seewoosagur Ramgoolam Medical College, Belle Rive, Mauritius.

Geriatrics and long term care Department, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.

出版信息

Nepal J Epidemiol. 2022 Sep 30;12(3):1220-1223. doi: 10.3126/nje.v12i3.48532. eCollection 2022 Sep.

DOI:10.3126/nje.v12i3.48532
PMID:36407052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9659683/
Abstract
摘要

相似文献

1
Treatment of Long COVID or Post COVID syndrome: A Pharmacological approach.长新冠或新冠后综合征的治疗：一种药理学方法。
Nepal J Epidemiol. 2022 Sep 30;12(3):1220-1223. doi: 10.3126/nje.v12i3.48532. eCollection 2022 Sep.
2
Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol.病毒性疾病后综合征（包括长新冠）的非药物治疗：系统评价和荟萃分析方案。
BMJ Open. 2022 Apr 11;12(4):e057885. doi: 10.1136/bmjopen-2021-057885.
3
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review.长新冠综合征管理和挑战的专家指导：系统综述。
Expert Opin Pharmacother. 2023 Feb;24(3):315-330. doi: 10.1080/14656566.2022.2161365. Epub 2023 Jan 1.
4
How do German General Practitioners Manage Long-/Post-COVID? A Qualitative Study in Primary Care.德国全科医生如何管理长新冠/后新冠？初级保健中的定性研究。
Viruses. 2023 Apr 20;15(4):1016. doi: 10.3390/v15041016.
5
Pharmacological Proposal Approach to Managing Chronic Pain Associated with COVID-19.管理与COVID-19相关的慢性疼痛的药理学建议方法
Biomedicines. 2023 Jun 24;11(7):1812. doi: 10.3390/biomedicines11071812.
6
Clinical trials on the pharmacological treatment of long COVID: A systematic review.长新冠的药物治疗临床试验：系统评价。
J Med Virol. 2023 Jan;95(1):e28289. doi: 10.1002/jmv.28289. Epub 2022 Nov 18.
7
Could Cognitive Behavioural Therapy Be an Effective Treatment for Long COVID and Post COVID-19 Fatigue Syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome.认知行为疗法能否有效治疗新冠长期症状和新冠后疲劳综合征？来自Q热疲劳综合征Qure研究的经验教训。
Healthcare (Basel). 2020 Dec 11;8(4):552. doi: 10.3390/healthcare8040552.
8
[Gender cardiology: focus on clinical and pathophysiological peculiarities in women with long COVID syndrome].[性别心脏病学：关注长期新冠综合征女性的临床和病理生理特点]
G Ital Cardiol (Rome). 2024 Jan;25(1):6-13. doi: 10.1714/4165.41585.
9
[Post-COVID syndrome-Focus fatigue].[新冠后综合征——聚焦疲劳]
Nervenarzt. 2022 Aug;93(8):788-796. doi: 10.1007/s00115-022-01306-1. Epub 2022 May 23.
10
Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.在一项回顾性病例系列研究中，鉴定与肌痛性脑脊髓炎/慢性疲劳综合征（ME/CFS）和长期新冠症状相关的CD8 T细胞功能障碍，并使用雾化抗氧化剂/抗病原体药物进行治疗。
Brain Behav Immun Health. 2023 Dec 27;36:100720. doi: 10.1016/j.bbih.2023.100720. eCollection 2024 Mar.

引用本文的文献

1
Exploring the psychological impact of long COVID: symptoms, mechanisms, and treatments.探索新冠长期症状的心理影响：症状、机制与治疗方法。
Front Psychiatry. 2025 Aug 19;16:1555370. doi: 10.3389/fpsyt.2025.1555370. eCollection 2025.
2
The Challenge of Long COVID: Is the Pandemic Really Over?长新冠的挑战：疫情真的结束了吗？
Public Health Rep. 2025 Aug 17:333549251358665. doi: 10.1177/00333549251358665.
3
Long COVID Response to Classical Chinese Medicine.长新冠对中医的反应
Integr Med (Encinitas). 2025 Apr;24(2):16-24.
4
Understanding Post-COVID-19: Mechanisms, Neurological Complications, Current Treatments, and Emerging Therapies.了解新冠后状况：机制、神经并发症、当前治疗方法及新兴疗法
Int J Gen Med. 2024 Dec 17;17:6303-6321. doi: 10.2147/IJGM.S499905. eCollection 2024.
5
Impact of Post-Acute Sequelae of COVID-19 on Lives of Patients Post-Intensive Care Unit Discharge: A Cross-Sectional Study.COVID-19 后急性后遗症对 ICU 出院后患者生活的影响：一项横断面研究。
Med Princ Pract. 2024;33(5):452-461. doi: 10.1159/000539781. Epub 2024 Jul 16.
6
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes-Results from a Multi-Center International Prospective Registry (HOPE-2).新冠病毒感染住院后肌钙蛋白升高与长期新冠症状：发病率、预后及临床结局——来自多中心国际前瞻性注册研究（HOPE-2）的结果
J Clin Med. 2024 Apr 28;13(9):2596. doi: 10.3390/jcm13092596.
7
Reduced Fatigue Symptoms in the Post-COVID Syndrome With Amifampridine: A Collective Casuistry With Double-Blind Discontinuation Trials.氨吡啶治疗新冠后综合征可减轻疲劳症状：一项双盲停药试验的综合病案分析
Cureus. 2024 Jan 25;16(1):e52935. doi: 10.7759/cureus.52935. eCollection 2024 Jan.
8
Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy.维生素 D 在 COVID-19 和长 COVID-19 中的药理学评价：最近的研究证实了临床验证，并强调二甲双胍可提高 VDR 敏感性和疗效。
Inflammopharmacology. 2024 Feb;32(1):249-271. doi: 10.1007/s10787-023-01383-x. Epub 2023 Nov 13.
9
Treatment of 95 post-Covid patients with SSRIs.使用 SSRIs 治疗 95 例新冠后患者。
Sci Rep. 2023 Nov 2;13(1):18599. doi: 10.1038/s41598-023-45072-9.
10
Online multimodal rehabilitation programme to improve symptoms and quality of life for adults diagnosed with long COVID-19: a Randomised Clinical Trial protocol.在线多模态康复方案改善长新冠成年人症状和生活质量的随机临床试验方案
Front Public Health. 2023 Sep 7;11:1222888. doi: 10.3389/fpubh.2023.1222888. eCollection 2023.

本文引用的文献

1
Post COVID syndrome: A novel challenge and threat to international health.新冠后遗症：对全球健康的新挑战与威胁。
Nepal J Epidemiol. 2022 Jun 30;12(2):1215-1219. doi: 10.3126/nje.v12i2.46149. eCollection 2022 Jun.
2
Symptoms and risk factors for long COVID in non-hospitalized adults.非住院成年人的长新冠症状和风险因素。
Nat Med. 2022 Aug;28(8):1706-1714. doi: 10.1038/s41591-022-01909-w. Epub 2022 Jul 25.
3
Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis.病例报告：吡非尼酮治疗新冠后肺纤维化
Front Med (Lausanne). 2022 Jun 6;9:925703. doi: 10.3389/fmed.2022.925703. eCollection 2022.
4
Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.2019冠状病毒病长期综合征中C-C趋化因子受体5的细胞表面水平降低与免疫抑制
Clin Infect Dis. 2022 Sep 30;75(7):1232-1234. doi: 10.1093/cid/ciac226.
5
Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial.适应原对新冠后综合征患者的疗效：一项随机、四重盲法、安慰剂对照试验
Pharmaceuticals (Basel). 2022 Mar 11;15(3):345. doi: 10.3390/ph15030345.
6
Long COVID and self-management.长期新冠与自我管理。
Lancet. 2022 Jan 22;399(10322):355. doi: 10.1016/S0140-6736(21)02798-7.
7
"LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy.“长新冠”-理解生物学基础和药物治疗策略的假说。
Pharmacol Res Perspect. 2022 Feb;10(1):e00911. doi: 10.1002/prp2.911.
8
A clinical case definition of post-COVID-19 condition by a Delphi consensus.德尔菲共识对新冠后状况的临床病例定义。
Lancet Infect Dis. 2022 Apr;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9. Epub 2021 Dec 21.
9
Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention.高压氧治疗长新冠：一种极具前景干预措施的早期评估。
Clin Med (Lond). 2021 Nov;21(6):e629-e632. doi: 10.7861/clinmed.2021-0462.
10
Long covid-mechanisms, risk factors, and management.长新冠的发病机制、危险因素和管理。
BMJ. 2021 Jul 26;374:n1648. doi: 10.1136/bmj.n1648.